A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)-Reference-Cited by-同舟云学术

A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)

Published:2016-09 Issue: Volume:48 Page:92-100
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ravandi Farhad^ORCID,Gojo Ivana,Patnaik Mrinal M.,Minden Mark D.,Kantarjian Hagop,Johnson-Levonas Amy O.,Fancourt Craig,Lam Raymond,Jones Mary Beth,Knox Clayton D.,Rose Shelonitda,Patel Payal Shah,Tibes Raoul

Funder

Merck

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference43 articles.

1. SEER Stat Fact Sheets: Acute Myeloid Leukemia (AML);National Cancer Institute,2015

2. Novel approaches to the treatment of acute myeloid leukemia;Roboz;Hematol. Am. Soc. Hematol. Educ. Program,2011

3. Meta-analysis of randomised clinical trials comparing idarubicin+cytarabine with daunorubicin+cytarabine as the induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia;Wang;PLoS One,2013

4. Acute myeloid leukaemia;Estey;Lancet,2006

5. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor biomarkers for diagnosis, prognosis and targeted therapy;Signal Transduction and Targeted Therapy;2024-05-20

2. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer;Journal of Cancer Research and Clinical Oncology;2024-03-23

3. Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials;Signal Transduction and Targeted Therapy;2023-09-06

4. The role of the MDM2/p53 axis in anti-tumor immune responses;Blood Journal;2023-07-19

5. The Development of p53-Targeted Therapies for Human Cancers;Cancers;2023-07-10